A mastectomy removes breast tissue to treat or reduce the risk of breast cancer. Traditional mastectomy removes the breast tissue plus the skin, nipple, and areola, leaving a flat chest. That outcome can be appropriate medically, but many patients struggle with body image and want reconstruction that looks and feels more like their previous breast.
What nipple-sparing mastectomy does differently
Nipple-sparing mastectomy removes only the breast tissue while preserving the breast skin and the nipple-areolar complex. Keeping the skin envelope gives reconstructive surgeons a better starting point to create a breast that more closely resembles a natural shape. According to James W. Jakub, M.D., preserving the entire skin envelope—including the nipple—provides the best chance to make the breast appear as if no mastectomy occurred.
What robotic-assisted nipple-sparing mastectomy changes
Surgeons at the Mayo Clinic describe a robotic approach that performs a minimally invasive nipple-sparing mastectomy through a smaller incision placed on the side of the breast rather than on the front. Moving the incision laterally can make the scar less visible, especially for smaller-breasted patients who lack tissue to hide a front incision.
- Incision location: side-of-breast rather than over the nipple.
- Working space: created with air (insufflation) instead of mechanical retractors.
- Intended effects: air may be gentler on the small blood vessels supplying the preserved skin and nipple, potentially reducing trauma and complication rates.
Potential patient benefits mentioned
- Less visible scarring for some body types.
- Possible protection of blood supply to the skin and nipple, which could reduce certain complications.
- Early evidence suggests the technique may help some women recover more sensation in the skin and nipple compared with conventional nipple-sparing mastectomy.
What we know about evidence and availability
Mayo Clinic was the only cancer program in Florida to participate in the clinical trials that evaluated the robotic-assisted nipple-sparing mastectomy. After recent FDA clearance, the robotic approach can now be offered to eligible patients outside of clinical trials. Mayo Clinic surgeons caution that research is still in early stages, and the longer-term comparative outcomes are not yet established.
What's left to decide at consultation
Whether nipple-sparing mastectomy—and specifically the robotic-assisted version—is appropriate depends on multiple patient-specific factors. The article does not list all candidate criteria, so an evaluation by a breast surgical team is required to determine eligibility and to review potential risks, reconstructive options, and expected recovery.
Robotic-assisted nipple-sparing mastectomy adds technical changes aimed at improving cosmetic outcomes and protecting skin and nipple blood supply. It is FDA-cleared and was studied in clinical trials that included Mayo Clinic. Early findings are promising for scarring and possible sensory benefits, but longer-term data and broader comparative research are still needed. Patients should discuss eligibility and trade-offs with their surgical and reconstructive teams.